Zimmer Biomet reported Street-beating Q1 results and upped its revenue guidance, though it cut its EPS projections amid ...

Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following ...

For the full year 2025, Zimmer Biomet lowered its adjusted earnings guidance to $7.90-$8.10 per share, below the consensus of $8.21, to account for its recent acquisition of Paragon 28 and currency ...

Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ETCompany ParticipantsDavid DeMartino - SVP, IRIvan Tornos ...

First quarter net sales of $1.909 billion increased 1.1% and 2.3% on a constant currency1 basis First quarter diluted earnings per share were $0.91; adjusted1 diluted ...

Q1 2025 Management View CEO Ivan Tornos highlighted a 2.3% constant currency sales growth for Q1 2025, with strong performance in U.S. Hips, which grew nearly 4%, and mid-single-digit growth in the S.